Human coronavirus OC43 is one of four seasonal coronaviruses responsible for a large share of common colds worldwide, typically producing a runny nose, sore throat, and mild cough that resolves on its own. It spreads primarily through respiratory droplets and aerosols released when an infected person coughs, sneezes, or talks, and secondarily through contaminated surfaces. Although most people encounter OC43 repeatedly throughout their lives without much trouble, the virus has some surprising properties, from an unusual ability to survive on surfaces to a capacity for invading the brain in rare cases, that set it apart from a generic “cold virus.”
A Betacoronavirus With a Bovine Past
OC43 belongs to the betacoronavirus genus, the same broad family that includes SARS-CoV-2 and MERS-CoV. Its full genome spans roughly 30,700 nucleotides and is strikingly similar to bovine coronavirus (BCoV), the virus that causes respiratory and intestinal disease in cattle.1PubMed Central. Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event That genetic closeness is the main reason researchers believe OC43 jumped from cattle to humans at some point in history. Molecular-clock analyses peg the split between OC43 and BCoV to roughly the late 1800s, and one provocative theory ties that jump to the so-called “Russian flu” pandemic of 1889–1892.
The Russian flu killed about a million people and was long assumed to be influenza. But phylogenetic studies showing OC43 diverged from BCoV around that same period, combined with contemporary reports of cross-species respiratory infections between livestock and humans during the pandemic, have led some researchers to propose that the 1889 outbreak was actually the debut of OC43 in humans.2PubMed Central. The enigma of the 1889 Russian flu pandemic: A coronavirus? Clinical descriptions from that era noted prominent neurological symptoms, including loss of taste and smell, which look more consistent with a coronavirus than with influenza.3PubMed Central. Clinical evidence that the pandemic from 1889 to 1891 commonly called the Russian flu might have been an earlier coronavirus pandemic The idea remains debated. A 2023 reassessment cautioned that the molecular evidence is not airtight and that an influenza origin cannot be ruled out.4PLoS ONE. Candidate historical events for the emergence of Human Coronavirus OC43: A critical reassessment of the molecular evidence Even so, if the theory holds, OC43 would be a real-world precedent for what happens when a lethal pandemic coronavirus eventually settles down into a mild seasonal pathogen, a trajectory some virologists have speculated SARS-CoV-2 could follow over decades.
How OC43 Gets Into Your Cells
Most respiratory viruses latch onto specific molecules on the surface of cells lining the nose and airway. OC43 uses a sugar-based target: it attaches to 9-O-acetylated sialic acids via its spike protein. A second surface protein, called hemagglutinin-esterase, acts as a receptor-destroying enzyme that helps the virus detach from decoy sugars on mucus so it can reach the actual cell surface.5PubMed Central. Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity This two-protein system is a balancing act: the spike grabs on, the esterase lets go. The two have coevolved to keep that balance tuned so the virus doesn’t get trapped in mucus before it ever reaches a cell.
Because 9-O-acetylated sialic acids are found on cells throughout the body, not just in the respiratory tract, OC43 has a broader tissue range than you might expect for a “cold” virus. That versatility is part of why it can, in rare circumstances, infect the brain.
Respiratory Droplets, Aerosols, and Surfaces
The primary transmission route is the same as for most respiratory viruses: when someone with an active OC43 infection coughs, sneezes, laughs, or even just breathes, they release droplets and smaller aerosol particles carrying the virus. Larger droplets settle within about a meter of the source; smaller aerosol particles can linger in poorly ventilated indoor air for longer. Close contact in enclosed spaces during winter months is the classic setup for transmission, which is why OC43 follows a predictable cold-weather pattern.
Surface (fomite) transmission is also possible, and OC43 turns out to be surprisingly hardy outside the body. On stainless steel, the virus can remain infectious for two days at typical indoor conditions, but at low humidity and cooler temperatures it survived throughout a 22-day experiment.6PubMed Central. Infectivity duration of HCoV-OC43, a surrogate for SARS-CoV-2, in artificial bodily fluids on stainless steel simulating common nonporous surfaces The presence of mucus-like material (mucin) extended survival further at moderate humidity, with the virus remaining infectious for up to 14 days. On human skin, OC43 has a median survival time of about 24.6 hours, roughly double what has been measured for SARS-CoV-2 under similar conditions.7PubMed Central. Evaluation of Environmental Stability and Disinfectant Effectiveness for Human Coronavirus OC43 on Human Skin Surface
The good news is that hand hygiene works. Despite OC43’s relatively high ethanol resistance compared to SARS-CoV-2, alcohol-based hand sanitizers with at least 50% ethanol completely inactivated the virus on skin within five seconds.7PubMed Central. Evaluation of Environmental Stability and Disinfectant Effectiveness for Human Coronavirus OC43 on Human Skin Surface Chlorhexidine and benzalkonium chloride also performed well. An older study found that on dried surfaces like aluminum, surgical gloves, and sponges, OC43 lost infectivity within about an hour, which is faster than the related seasonal coronavirus 229E.8PubMed Central. Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections The discrepancy between that finding and the longer survival on steel likely reflects differences in surface material, humidity, and the protective effect of body fluids like mucus. The practical takeaway is that dry, porous surfaces are low risk, but mucus-contaminated hard surfaces in cold, dry rooms can harbor the virus for days.
Seasonal Rhythm and Who Catches It
OC43 is the most commonly detected of the four seasonal coronaviruses. In the United States, the combined seasonal coronavirus season typically begins around late October, peaks in January or February, and fades by April or May, lasting about 25 weeks on average.9Emerging Infectious Diseases. Seasonality of Common Human Coronaviruses, United States, 2014–2021 Among the two betacoronaviruses, OC43 and HKU1 tend to alternate as the dominant strain in a biennial pattern, though in some years they co-circulate at similar levels.9Emerging Infectious Diseases. Seasonality of Common Human Coronaviruses, United States, 2014–2021 Globally, activity peaks during winter and spring in temperate climates, with less defined seasonality closer to the equator.10PubMed Central. Global Epidemiology and Seasonality of Human Seasonal Coronaviruses: A Systematic Review
Virtually everyone catches OC43 at some point during childhood, and most adults get reinfected multiple times over their lives. A long-running Dutch study that monitored healthy individuals for over 35 years found that reinfection with the same seasonal coronavirus frequently occurred at 12 months after the previous infection, and sometimes as early as six months.11Nature Medicine. Seasonal coronavirus protective immunity is short-lasting A separate study of a cohort of children and adults found no significant difference between the probability of an initial infection and the probability of reinfection with OC43 by about 34 weeks, reinforcing that immunity fades quickly.12PubMed Central. Direct Observation of Repeated Infections With Endemic Coronaviruses The same study noted that the innate immune response may matter more for determining how sick you get than the memory left over from your last infection.
Usually Mild, Sometimes Not
Together, the four seasonal coronaviruses are estimated to account for roughly 15% to 30% of common colds in adults.13Encyclopedia of Virology. Viruses as Infectious Agents: Human and Animal Viruses For a healthy adult, an OC43 infection is usually indistinguishable from any other cold: congestion, sore throat, mild cough, sometimes a low-grade fever, resolving in a week or so. No specific treatment is needed beyond rest and fluids.
Severe disease is uncommon but real, and it clusters in predictable groups. A French study of OC43 cases severe enough to require intensive care found that the patients averaged 71 years of age and had high rates of diabetes, chronic lung disease, and chronic kidney disease; nearly half required mechanical ventilation.14PubMed Central. Intensive care admission for Coronavirus OC43 respiratory tract infections Infants and people with compromised immune systems are also at elevated risk. An autopsy-confirmed case of fatal OC43 encephalitis was documented in an infant born without a functional thymus and suffering from chronic T-cell deficiency.15PubMed Central. Neuroinvasive potential of human coronavirus OC43: case report of fatal encephalitis in an immunocompromised host Co-infections with other respiratory viruses can also complicate matters; a case report described an 81-year-old man hospitalized with a simultaneous triple infection of OC43, respiratory syncytial virus, and rhinovirus.16PubMed Central. Back to the future of viruses: a case of triple coinfection caused by respiratory syncytial virus, human coronavirus OC43, and rhinovirus
OC43’s Ability to Invade the Brain
One of the more unsettling aspects of OC43 is its well-documented neurotropism. In mouse experiments, the virus reached the central nervous system after being introduced through the nose, infected neurons throughout the brain, and caused acute encephalitis with neuron death.17PubMed Central. Vacuolating encephalitis in mice infected by human coronavirus OC43 Mice that survived the acute phase sometimes went on to develop long-term motor problems. In one study, viral RNA persisted in the brain for months after infectious virus had been cleared, and some surviving animals showed progressive loss of motor activity and abnormal reflexes.18PubMed Central. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice
How relevant is this to humans? Severe OC43 encephalitis in people is extremely rare and essentially only documented in immunocompromised individuals. But the mouse data has made OC43 a popular laboratory model for studying how coronaviruses in general can affect the nervous system. Two distinct OC43 variants have been shown to reach the brain after nasal inoculation in mice, confirming this is a stable trait of the virus rather than a fluke of one lab strain.19PubMed Central. Human respiratory coronavirus OC43: genetic stability and neuroinvasion For most people with functioning immune systems, there is no reason to worry about brain infection from a typical OC43 cold. But researchers have speculated that low-level persistence of viral RNA in neural tissue could theoretically contribute to subtle long-term effects, and this question remains open.
Diagnosis and Why It Rarely Happens
Most OC43 infections are never formally diagnosed because they look identical to colds caused by rhinoviruses, other coronaviruses, or adenoviruses, and testing would not change the treatment plan. When a clinician does want to identify the specific pathogen, typically in a hospitalized patient or someone with an unusually severe course, the standard tool is multiplex PCR. Panels like the BioFire FilmArray Respiratory Panel can simultaneously screen a single nasal swab for dozens of respiratory pathogens, including all four seasonal coronaviruses.20PubMed Central. Pneumonia Due to Human Coronavirus OC43 in an Immunocompetent Adult Detected by Multiplex Polymerase Chain Reaction These panels became more widely used during the COVID-19 pandemic because distinguishing SARS-CoV-2 pneumonia from other viral pneumonias had direct treatment implications. A large-scale UK study using a multiplex real-time PCR assay screened over 11,000 respiratory samples and showed how such tools can reveal coronaviruses that would otherwise go undetected.21PubMed Central. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method
Treatment Landscape
There is no approved antiviral specifically targeting OC43. For the vast majority of infections, none is needed. In the rare cases of severe OC43 disease, particularly encephalitis in immunocompromised patients, clinicians have turned to off-label options. A 2025 case report described a 65-year-old immunocompromised man whose OC43 encephalitis had worsened over three months before treatment with remdesivir, the antiviral developed for Ebola and repurposed during the COVID-19 pandemic. His consciousness improved dramatically within a week of starting the drug.22PubMed Central. Remdesivir for the Treatment of Human Coronavirus OC43 Encephalitis
Lab research has also identified other potential antivirals. Brilacidin, originally developed as an antimicrobial peptide mimic, showed broad activity against OC43, 229E, and NL63 in cell culture, and had a strong synergistic effect when combined with remdesivir against OC43.23PubMed Central. Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell A separate group found that drugs inhibiting an enzyme called PAD4 suppressed OC43 replication in human lung cells and also worked against SARS-CoV-2 in a different cell system.24PubMed Central. Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 None of these candidates have reached human trials for OC43 specifically, and given that the infection is almost always mild, the commercial incentive to develop them is low. Their real significance may be as tools against future coronavirus outbreaks rather than against OC43 itself.
Cross-Reactive Immunity and the SARS-CoV-2 Connection
When the COVID-19 pandemic arrived, researchers quickly noticed that some people who had never been exposed to SARS-CoV-2 already had immune cells that reacted to it. A major explanation was prior infection with seasonal coronaviruses like OC43. Studies found pre-existing memory T cells in roughly 30% of unexposed individuals that could recognize both OC43 and SARS-CoV-2 proteins.25Journal of Leukocyte Biology. Cross-reactive cellular, but not humoral, immunity is detected between OC43 and SARS-CoV-2 NPs in people not infected with SARS-CoV-2: Possible role of cTFH cells Another study demonstrated pre-existing memory T cells with comparable ability to bind SARS-CoV-2 and all four common cold coronaviruses.26PubMed Central. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
The cross-reactivity was not evenly distributed across the immune system. The T cell response crossed over, but antibodies did not: blood samples collected before the pandemic showed no antibody cross-reactivity between OC43 and SARS-CoV-2.25Journal of Leukocyte Biology. Cross-reactive cellular, but not humoral, immunity is detected between OC43 and SARS-CoV-2 NPs in people not infected with SARS-CoV-2: Possible role of cTFH cells And the cross-reactive T cells appeared to have limitations. They stimulated only weak activation of follicular helper T cells, a type of immune cell needed to drive strong antibody production. Further work in a hamster model showed that prior OC43 infection didn’t meaningfully reduce weight loss or viral replication when the animals were later challenged with SARS-CoV-2, though it did leave a distinct T cell gene signature.27Research Square. Signatures of Original Antigenic Sin or protection following coronavirus imprinting in Syrian hamsters challenged with SARS-CoV-2 or variants In practical terms, having caught OC43 before probably gave your T cells a modest head start against SARS-CoV-2, but it was far from a substitute for vaccination or natural SARS-CoV-2 infection in generating protective antibodies.
Research on the T cell overlap also identified specific pieces of viral protein where the cross-reactivity was sharpest. One study found that CD8+ T cells generated against a SARS-CoV-2 peptide showed a strong cross-reactive response against the corresponding OC43 peptide in most unexposed donors tested.28Immunity. Shared T cell receptor recognition spaces targeted by cross-reactive coronavirus specific T cell responses That kind of finding matters for vaccine design: if future pan-coronavirus vaccines target regions shared across the family, prior exposure to mundane viruses like OC43 could prime the immune system to respond faster.
The Virus Keeps Changing
OC43 is not a single unchanging virus. It continuously evolves, and researchers now classify its strains into at least 11 phylogenetic groups, labeled A through K.29International Journal of Infectious Diseases. Epidemiology and genetic diversity of common human coronaviruses in Beijing, 2015-2023: A prospective multicenter study In Beijing, the dominant group shifted from Group I in 2016–2017 to Group K from 2018 onward, and the Group K strains circulating there resembled sequences from the United States and Japan during the same period, pointing to global mixing.29International Journal of Infectious Diseases. Epidemiology and genetic diversity of common human coronaviruses in Beijing, 2015-2023: A prospective multicenter study A multicenter surveillance study confirmed that OC43, along with 229E and NL63, continuously generates new lineages.30PubMed. Continuous evolution and emerging lineage of seasonal human coronaviruses: A multicenter surveillance study
This ongoing drift is likely one reason why immunity to OC43 is so short-lived. Even if your immune system mounts a strong response to the version of OC43 you caught last winter, the strain circulating this winter may have changed enough at key sites that your antibodies are less effective. The dynamics resemble a much gentler version of what happens with influenza, where antigenic drift forces annual vaccine updates. No one is developing annual OC43 vaccines, of course. The virus causes too little serious illness to justify that effort. But its perpetual shape-shifting helps explain why it remains a permanent fixture of the winter respiratory season rather than something you catch once and become immune to for life.